Marc Broudy
About Marc Broudy
Marc Broudy is a Scientist specializing in Global Quality Analytical Science and Technology at Bristol-Myers Squibb in Devens, MA, with over 15 years of experience in analytical development.
Title
Marc Broudy is a Scientist in Global Quality Analytical Science and Technology at Bristol-Myers Squibb.
Experience at Bristol-Myers Squibb
Marc Broudy currently works at Bristol-Myers Squibb in Devens, MA. In his role as a Scientist in Global Quality Analytical Science and Technology, he applies his extensive experience in analytical development and drug analysis. His work focuses on providing analytical support for process chemistry, and supporting IND and NDA filings for oncology candidates. He ensures compliance with GMP/GLP, ICH, and 21 CFR Part 11 requirements.
Previous Roles and Industry Experience
Marc Broudy has over 15 years of experience in the biopharmaceutical industry. Before joining Bristol-Myers Squibb, he worked at various respected companies. He was a Validation and Tech Transfer Specialist at Ipsen in Cambridge, MA, from 2016 to 2019. He held the position of Associate Scientist at Synta Pharmaceuticals in Lexington, MA, from 2011 to 2015. Earlier in his career, he was a Senior Research Associate at ARIAD Pharmaceuticals, Inc., in Cambridge, MA, from 2004 to 2010. He also worked as a Research Scientist at Gentest Corporation / BD Biosciences in Woburn, MA, from 1999 to 2003.
Education and Technical Expertise
Marc Broudy earned his Bachelor's degree in Chemistry from Kenyon College, where he studied from 1989 to 1993. He is skilled in the development, optimization, validation, and transfer of analytical methods, providing essential support for various stages of drug development and analysis. His expertise includes a wide range of analytical techniques like HPLC, LC/MS, LC/MS/MS, GC, IR, UV-Vis, and KF. He also has extensive experience with ADME and DMPK.
Key Skills and Specializations
Marc Broudy specializes in analytical method development, focusing on the characterization, release, and stability testing of drug products, drug substances, and raw materials/excipients. He plays a crucial role in supporting process chemistry and regulatory filings such as IND and NDA. His work ensures adherence to compliance requirements including GMP/GLP, ICH, and 21 CFR Part 11. His broad technical expertise in various analytical techniques makes him a valuable asset in the pharmaceutical industry.